Intervention not reported
Days of catheter patency · Children with central venous catheter
1 finding from 1 review
Intervention not reported
Catheter‐related thrombosis at any time during catheter stay · Children with central venous catheter
The intervention showed no clear difference in catheter‐related thrombosis at any time during catheter stay (moderate certainty).
1 finding from 1 review
Intervention not reported
Occlusion of catheter within one week of catheter insertion · Children with central venous catheter
The intervention showed no clear difference in occlusion of catheter within one week of catheter insertion (low certainty).
1 finding from 1 review
Intervention not reported
Catheter‐related blood stream infection and CVC‐related colonization · Children with central venous catheter
The intervention may leads to lower catheter‐related blood stream infection and CVC‐related colonization (low certainty).
1 finding from 1 review
Intervention not reported
Side effects: Thrombocytopenia after catheter insertion · Children with central venous catheter
The intervention showed no clear difference in side effects: Thrombocytopenia after catheter insertion (low certainty).
1 finding from 1 review
Total VTE · 17,802 patients with low to normal levels of low density lipoprotein (LDL) cholesterol (< 130 mg/dL)
Statin probably leads to lower all cases of VTE compared with placebo (moderate certainty).
1 finding from 1 review
Pulmonary embolism · 17,802 patients with low to normal levels of low density lipoprotein (LDL) cholesterol (< 130 mg/dL)
1 finding from 1 review
Deep vein thrombosis · 17,802 patients with low to normal levels of low density lipoprotein (LDL) cholesterol (< 130 mg/dL)
1 finding from 1 review
Any MI · 17,802 patients with low to normal levels of low density lipoprotein (LDL) cholesterol (< 130 mg/dL)
Statin probably leads to lower any MI compared with placebo (moderate certainty).
1 finding from 1 review
Stroke · 17,802 patients with low to normal levels of low density lipoprotein (LDL) cholesterol (< 130 mg/dL)
Statin probably leads to lower any stroke compared with placebo (moderate certainty).
1 finding from 1 review
Death · 17,802 patients with low to normal levels of low density lipoprotein (LDL) cholesterol (< 130 mg/dL)
Statin probably leads to lower death compared with placebo (moderate certainty).
1 finding from 1 review
Any serious adverse event · 17,802 patients with low to normal levels of low density lipoprotein (LDL) cholesterol (< 130 mg/dL)
Statin showed no clear difference in any serious adverse event compared with placebo (moderate certainty).
1 finding from 1 review
Deep vein thrombosis · patients with prevention of deep vein thrombosis1
It is very uncertain whether knee length changes deep vein thrombosis (Fixed‐effect analysis) Venous duplex scan,… compared with thigh length graduated compression stockings (very low certainty).
3 findings from 1 review
OR 1.55 [0.78, 3.07]
3 studies · 496 participants
Very low
OR 1.32 [0.43, 4.06]
3 studies · 496 participants
Very low
no estimate extracted
3 studies · 496 participants
Very low
Major VTE events bilateral ascending venography1 · patients with prevention of venous thromboembolism following total hip or knee replacement
Direct thrombin inhibitors showed no clear difference in major VTE events bilateral ascending venography1 compared with low molecular weight heparins (low certainty).
1 finding from 1 review
All‐cause Mortality events · patients with prevention of venous thromboembolism following total hip or knee replacement
Direct thrombin inhibitors probably leads to higher all‐cause Mortality events compared with low molecular weight heparins (moderate certainty).
1 finding from 1 review
Total Bleeding events · patients with prevention of venous thromboembolism following total hip or knee replacement
Direct thrombin inhibitors showed no clear difference in total Bleeding events compared with low molecular weight heparins (low certainty).
1 finding from 1 review
ALT >3 times the upper normal limit · patients with prevention of venous thromboembolism following total hip or knee replacement
Direct thrombin inhibitors may leads to lower ALT >3 times the upper normal limit compared with low molecular weight heparins (low certainty).
1 finding from 1 review
Major VTE events in TKR combined doses bilateral ascending venography · patients with prevention of venous thromboembolism following total hip or knee replacement
Direct thrombin inhibitors showed no clear difference in major VTE events in TKR combined doses bilateral ascending venography compared with vitamin K antagonists (low certainty).
1 finding from 1 review
All‐cause Mortality events in TKR combined doses · patients with prevention of venous thromboembolism following total hip or knee replacement
Direct thrombin inhibitors showed no clear difference in all‐cause Mortality events in TKR combined doses compared with vitamin K antagonists (low certainty).
1 finding from 1 review
Total Bleeding events in TKR combined doses · patients with prevention of venous thromboembolism following total hip or knee replacement
Direct thrombin inhibitors showed no clear difference in total Bleeding events in TKR combined doses compared with vitamin K antagonists (low certainty).
1 finding from 1 review